Helix BioPharma (HBP) Stock Chart & Stock Price History C$1.00 +0.02 (+2.04%) As of 07/17/2025 03:52 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Helix BioPharma Stock Price Performance The Helix BioPharma (HBP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 334.78%, with a year-to-date return of 12.36%. In the past month, the stock has increased 8.70%, reflecting recent market activity. As of the latest close, Helix BioPharma traded at C$1.00 with a market cap of C$53.02 million and volume of 34,505 shares. Five years ago, the stock traded at C$0.55, representing a 81.82% increase over that period. At the time, it had a market cap of C$79.76 million and a volume of 4,000 shares. Receive HBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.09%1 Month Performance+8.70%3 Month PerformanceN/AYear-To-Date Performance+12.36%1 Year PerformanceN/A5 Year Performance+81.82% HBP Stock Chart for Friday, July, 18, 2025 HBP Chart by TradingView Helix BioPharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025C$0.98C$1.00+2.04%C$1.00C$0.9834,505 shsC$53.02 million07/16/2025C$0.97C$0.98+1.03%C$0.98C$0.9534,076 shsC$51.96 million07/15/2025C$0.97C$0.97C$0.97C$0.971,100 shsC$51.43 million07/14/2025C$0.97C$0.97C$0.97C$0.971,357 shsC$51.43 million07/11/2025C$0.97C$0.97C$0.97C$0.971,357 shsC$51.43 million07/08/2025C$0.97C$0.97C$0.97C$0.973,000 shsC$51.43 million07/07/2025C$0.97C$0.97C$0.97C$0.973,000 shsC$51.43 million07/04/2025C$0.97C$0.97C$0.97C$0.973,000 shsC$51.43 million07/03/2025C$0.97C$0.97C$0.97C$0.97500 shsC$51.43 million07/02/2025C$0.93C$0.97+4.30%C$0.97C$0.971,000 shsC$51.43 million Get the Latest News and Ratings for HBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025C$0.93C$0.93C$0.93C$0.843,624 shsC$49.31 million06/30/2025C$0.95C$0.93-2.11%C$0.93C$0.843,624 shsC$49.31 million06/27/2025C$0.93C$0.95+2.15%C$0.95C$0.9319,100 shsC$50.37 million06/26/2025C$0.93C$0.93C$0.93C$0.932,000 shsC$49.31 million06/25/2025C$0.93C$0.93C$0.93C$0.932,000 shsC$49.31 million06/24/2025C$0.93C$0.93C$0.93C$0.903,100 shsC$49.31 million06/23/2025C$0.90C$0.93+3.33%C$0.93C$0.911,000 shsC$49.31 million06/20/2025C$0.90C$0.90C$0.90C$0.90500 shsC$47.72 million06/19/2025C$0.92C$0.90-2.17%C$0.90C$0.901,000 shsC$47.72 million06/18/2025C$0.91C$0.92+1.10%C$0.92C$0.92500 shsC$48.78 million06/17/2025C$0.91C$0.91C$0.92C$0.911,600 shsC$48.25 million Related Companies Theratechnologies Stock Chart Oncolytics Biotech Stock Chart Aptose Biosciences Stock Chart Covalon Technologies Stock Chart Medicenna Therapeutics Stock Chart Sernova Stock Chart Microbix Biosystems Stock Chart Devonian Health Group Stock Chart Hemostemix Stock Chart Sirona Biochem Stock Chart Receive HBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:HBP) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
